2013
DOI: 10.1111/dom.12058
|View full text |Cite
|
Sign up to set email alerts
|

Current therapeutic interventions in the glycation pathway: evidence from clinical studies

Abstract: The increased formation of advanced glycation endproducts (AGEs) constitutes a potential mechanism of hyperglycaemia-induced micro- and macrovascular disease in diabetes. In vitro and animal experiments have shown that various interventions can inhibit formation and/or actions of AGEs, in particular the specific AGE inhibitor aminoguanidine and the AGEs crosslink breaker alagebrium, and the B vitamins pyridoxamine and thiamine, and the latter's synthetic derivative, benfotiamine. The potential clinical value o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
86
0
4

Year Published

2014
2014
2021
2021

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 105 publications
(90 citation statements)
references
References 163 publications
(220 reference statements)
0
86
0
4
Order By: Relevance
“…2e). Low thiamine blood levels have been linked to complications of T1DM 48 and colonic uptake transporters of thiamine have been described 49 . However, the observed patterns in transcript abundances of thiazole synthase and plasma thiamine levels were not correlated in the small subset of individuals who did not take thiamine supplements, precluding any conclusions (Supplementary Section 18 and Supplementary Fig.…”
Section: Human Protein Excretion In T1dm and Microbial Functionsmentioning
confidence: 99%
“…2e). Low thiamine blood levels have been linked to complications of T1DM 48 and colonic uptake transporters of thiamine have been described 49 . However, the observed patterns in transcript abundances of thiazole synthase and plasma thiamine levels were not correlated in the small subset of individuals who did not take thiamine supplements, precluding any conclusions (Supplementary Section 18 and Supplementary Fig.…”
Section: Human Protein Excretion In T1dm and Microbial Functionsmentioning
confidence: 99%
“…Indeed, it has been shown that alagebrium is able to reduce large artery stiffening in animal models. 36 One double-blind randomized controlled trial correspondingly showed a decrease in pulse pressure and cfPWV in individuals who received alagebrium. 37 However, another double-blind randomized controlled trial Figure. Associations between measures of advanced glycation end product (AGE) accumulation and carotid to femoral pulse-wave velocity (cfPWV) or central pulse pressure (cPP) in individuals with normal glucose metabolism (NGM), impaired glucose metabolism (IGM), and type 2 diabetes mellitus (T2DM).…”
mentioning
confidence: 99%
“…[42][43][44] As GNPs can be used in vivo and can be readily prepared, a deeper understanding of their antiglycation potential may lead to novel therapeutic approaches for treating diseases whose complications relate to the formation of AGEs.…”
Section: Discussionmentioning
confidence: 99%